Zamaz plc announced Martin Groak, (Chairman), and Daniele Besnati, (COO), who retired in accordance with Company's Articles of Association, have been re-elected to the Board. Christopher Hill, (CEO), who also retired, did not seek re-election to the Board but will remain with the Company, focused on sourcing and acquiring retail and e-commerce businesses and brands. Mr. Besnati will be taking over the role of Group CEO (previously COO).

Dominic White, who is the Company's beneficial shareholder, has been appointed to the Board as a non-executive director. He was previously Chairman of the Company from its formation until November 2021. Dominic is a Member of the Institute of Financial Analysts and has over 25 years' experience in the investment sector.

He has held Board level investment positions at international institutions including Security Capital, European Realty, Henderson Global Investors and Cordea Savills Invest Management and is currently Chairman of Eight Capital Partners plc, an international tech-orientated financial services group listed on the AQSE Growth Market; Dr. Niccolo` Caderni has also been appointed as an independent non-executive director. After an academic career in Astrophysics at the Universities of Cambridge, California and Chicago, Dr. Caderni has since established a life-long practice in the financing and management of innovation and creativity. He has covered senior executive roles with Bankers Trust, Phillips Fine Art Auctioneers, the Bentinck Thyssen family office, and has served on the Board of the Centre for European Policy Studies in Brussels.

In 1999 he co-founded IPG, an incubator focusing on the delivery of digital content and was later elected Chairman of Webiz BV, the Private Equity fund of Italian utility giant ENEL. Currently, Dr. Caderni holds a portfolio of advisory and non-executive roles, chiefly in digital transformation and in life science, is a member of the European Institute of Technology Culture and Creativity Supervisory Board, and is the Chairman of RAFT, a leading medical research charity and a Trustee of the Chelsea Academy Foundation.